Abbott Labs completes $123M deal for Starlims
Abbott Laboratories said Monday it completed its purchase of Starlims Technology, which makes software used to manage laboratory testing.
Abbott agreed to buy Starlims in December for $123 million, or $14 per share. The company said it bought Hollywood, Fla., company to increase its position in the diagnostic testing market.
Shares of Abbott rose 41 cents to close at $53.87.